“Bimekizumab Efficacy and Safety in Patients With Psoriatic Arthritis Who Had Skin and Nail Psoriasis at Baseline: Up to 2-year Results From Two Phase 3 Studies” (2024) SKIN The Journal of Cutaneous Medicine, 8(6), p. s435. doi:10.25251/skin.8.supp.435.